TITLE:
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease

CONDITION:
Mitochondrial Diseases

INTERVENTION:
RG2133 (2',3',5'-tri-O-acetyluridine)

SUMMARY:

      The objective of the study is to determine the safety and tolerability of RG2133 in patients
      with Mitochondrial Disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 3 Years to N/A
Criteria:

        Mitochondrial Disease
      
